Find a Clinical Trial

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Lung Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

A Phase III, Randomized, Double-Blind, Placebo-controlled study of Atezolizumab plus Carboplatin and Etoposide with or without Tiragolumab (Anti-Tigit Antibody) in patients with untreated extensive-stage small cell lung cancer (GO41767)

  • Details

ClinicalTrials.gov ID: NCT04256421
Diagnosis Type: NA
USOR Number: 19193

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
36.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Lung Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

20190009: A Phase 3 Multicenter, Randomized, Open Label, Active-controlled, Study of AMG 510 Versus Docetaxel for the Treatment of Previously Treated Locally Advanced and Unresectable or Metastatic NSCLC Subjects with Mutated KRAS p.G12C

  • Details

ClinicalTrials.gov ID: NCT04303780
Diagnosis Type: NA
USOR Number: 19143

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
36.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Lung Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

An Adaptive Phase III, Multicenter, Randomized, Open-Label, Controlled Study of M7824 (bintrafusp alfa) versus Pembrolizumab as a First-line Treatment in Patients with PD-L1 Expressing Advanced Non-small Cell Lung Cancer(MS200647-0037)

  • Details

ClinicalTrials.gov ID: NCT03631706
Diagnosis Type: NSCLC
USOR Number: 18065

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
36.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Lung Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

A phase III, multicenter, randomized, double blind, placebo-controlled study evaluating the efficacy and safety of canakinumab versus placebo as adjuvant therapy in adult subjects with stages AJCC/UICC v. 8 II-IIIA and IIIB (T>5cm N2) completely resected (R0) non-small cell lung cancer (NSCLC)(CACZ885T2301)

  • Details

ClinicalTrials.gov ID: NCT03447769
Diagnosis Type: NA
USOR Number: 17167

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
36.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Breast Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

A phase II, multicenter, randomized, open-label study to evaluate the safety and efficacy of 400 mg of ribociclib in combination with non-steroidal aromatase inhibitors for the treatment of pre- and postmenopausal women with hormone receptor-positive, HER2-negative advanced breast cancer who received no prior therapy for advanced disease (CLEE011A2207)

  • Details

ClinicalTrials.gov ID: NCT03822468
Diagnosis Type: NA
USOR Number: 19004

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
36.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Bladder Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

A study of enfortumab vedotin (ASG-22CE) as monotherapy or in combination with other anticancer therapies for the treatment of urothelial cancer (SGN22E-002)

  • Details

ClinicalTrials.gov ID: NCT03288545
Diagnosis Type: NA
USOR Number: 20172

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
36.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

A study of enfortumab vedotin (ASG-22CE) as monotherapy or in combination with other anticancer therapies for the treatment of urothelial cancer (SGN22E-002)

  • Details

ClinicalTrials.gov ID: NCT03288545
Diagnosis Type: NA
USOR Number: 20172

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
36.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

A Phase 1b-2 Study of Niraparib Combination Therapies for the Treatment of Metastatic Castration-Resistant Prostate Cancer (PCR2002 Quest) (64091742PCR2002)

  • Details

ClinicalTrials.gov ID: NCT03431350
Diagnosis Type: NA
USOR Number: 19146

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
36.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Biliary Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

A Phase III Open-Label, Multi-Centre, Randomised Study Comparing NUC-1031 plus Cisplatin to Gemcitabine plus Cisplatin in Patients with Previously Untreated Locally Advanced or Metastatic Biliary Tract Cancer (NuTide:121)

  • Details

ClinicalTrials.gov ID: NCT04163900
Diagnosis Type: NA
USOR Number: 19120

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
36.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Leukemia

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

A Phase 3, Randomized Study of Zanubrutinib (BGB-3111) Compared with Ibrutinib in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (BGB-3111-305)

  • Details

ClinicalTrials.gov ID: NCT03734016
Diagnosis Type: CLL
USOR Number: 18155

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
36.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Lymphomas

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

A Phase 3, Randomized Study of Zanubrutinib (BGB-3111) Compared with Ibrutinib in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (BGB-3111-305)

  • Details

ClinicalTrials.gov ID: NCT03734016
Diagnosis Type: Non-Hodgkins
USOR Number: 18155

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
36.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

A Phase 2, Randomized, Double-blind, Placebo-Controlled Study of Abiraterone Acetate Plus Prednisone with or without Abemaciclib in Patients with Metastatic Castration-Resistant Prostate Cancer (I3Y-MC-JPCM)

  • Details

ClinicalTrials.gov ID: NCT03706365
Diagnosis Type: NA
USOR Number: 18128

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
36.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Myelomas

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

(Amgen 20180015) A Randomized, Open-label, Phase 3 Study Comparing Once-weekly vs Twice-weekly Carfilzomib in Combination with Lenalidomide and Dexamethasone in Subjects with Relapsed or Refractory Multiple Myeloma (A.R.R.O.W.2).

  • Details

ClinicalTrials.gov ID: NCT03859427
Diagnosis Type: NA
USOR Number: 19036

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
36.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

A Phase II Open Label, Study of IMMU-132 in Metastatic Urothelial Cancer After Failure of Platinum-Based Regimen or Anti-PD-1/PD-L1 Based Immunotherapy (IMMU-132-06)

  • Details

ClinicalTrials.gov ID: NCT03547973
Diagnosis Type: ALL
USOR Number: 18283

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
36.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Myelomas

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

A Randomized Study of Daratumumab Plus Lenalidomide Versus Lenalidomide Alone as Maintenance Treatment in Patients with Newly Diagnosed Multiple Myeloma Who Are Minimal Residual Disease Positive After Frontline Autologous Stem Cell Transplant (54767414MMY3021)

  • Details

ClinicalTrials.gov ID: NCT03901963
Diagnosis Type: NA
USOR Number: 19247

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
36.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Endometrial Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

D9311C00001; GOG-3041; ENGOT-EN10: A Randomised, Multicentre, Double-blind, Placebo-controlled, Phase III Study of First-line Carboplatin and Paclitaxel in Combination with Durvalumab, Followed by Maintenance Durvalumab with or without Olaparib in Patients with Newly Diagnosed Advanced or Recurrent Endometrial Cancer (DUO-E)

  • Details

ClinicalTrials.gov ID: NCT04269200
Diagnosis Type: NA
USOR Number: 19221

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
36.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Breast Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

Phase 3 Study of Sacituzumab Govitecan (IMMU-132) Versus Treatment of Physician's Choice (TPC) in subjects with Hormonal Receptor-Positive (HR+) Human Epidermal Growth Factor Receptor 2 (HER2) Negative Metastatic Breast Cancer (MBC) who have failed at least two prior chemotherapy regimens (IMMU-132-09)

  • Details

ClinicalTrials.gov ID: NCT03901339
Diagnosis Type: NA
USOR Number: 18282

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
36.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

A Phase 3 Randomized, Placebo-controlled, Double-blind Study of Niraparib in Combination with Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Subjects with Metastatic Prostate Cancer(64091742PCR3001)

  • Details

ClinicalTrials.gov ID: NCT03748641
Diagnosis Type: NA
USOR Number: 18103

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
36.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Gall Bladder Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

A Phase 3 Multicenter, Open-Label, Randomized, Controlled Study of Oral Infigratinib versus Gemcitabine with Cisplatin in Subjects with Advanced/Metastatic or Inoperable Cholangiocarcinoma with FGFR2 Gene Fusions/Translocations: The PROOF Trial (QBGJ398-301)

  • Details

ClinicalTrials.gov ID: NCT03773302
Diagnosis Type: NA
USOR Number: 18264

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
36.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Lung Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

A PHASE III, RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED STUDY OF TIRAGOLUMAB, AN ANTI-TIGIT ANTIBODY,IN COMBINATION WITH ATEZOLIZUMAB COMPARED WITH PLACEBO IN COMBINATION WITH ATEZOLIZUMAB IN PATIENTS WITH PREVIOUSLY UNTREATED LOCALLY ADVANCED UNRESECTABLE OR METASTATIC PD-L1-SELECTED NON-SMALL CELL LUNG CANCER (GO41717)

  • Details

ClinicalTrials.gov ID: NCT04294810
Diagnosis Type: NSCLC
USOR Number: 19192

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
36.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Pages